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CLINICAL STUDY
Real-time PCR improves detection of Trichomonas vaginalis infection
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Abstract
Objective. To compare a real-time polymerase chain reaction (PCR) assay with broth culture for the detection of
Trichomonas vaginalis using self-collected vaginal swabs.
Methods. Self-collected vaginal swabs were obtained from adolescent and young adult African-American women
participating in HIV-1 prevention programs. T. vaginalis culture was performed using the InPouch TV System. Samples
for the real-time PCR assay were collected using the BDProbeTec ET Culturette Direct Dry Swab system and tested in a
laboratory-developed assay which targeted a repeated sequence of the genome. Discrepant samples that were culture
negative and positive in the real-time PCR assay were tested in a conﬁrmatory PCR which targeted a different region of the
T. vaginalis genome, the18S ribosomal DNA gene.
Results. Of the 524 specimens tested by both culture and real-time PCR, 36 were culture positive and 54 were positive in
the real-time PCR assay; 16 of the 18 discrepant specimens were also positive in the conﬁrmatory PCR assay. Using a
modiﬁed gold standard of positive by culture or positive in both PCR assays, the sensitivity of the real-time PCR assay was
100% and the speciﬁcity was 99.6%, whereas culture had a sensitivity of 69.2% and a speciﬁcity of 100%.
Conclusions. The real-time PCR assay was sensitive and speciﬁc for the detection of T. vaginalis DNA from self-collected
vaginal swab specimens. The ability to use the BDProbeTec dry swab system for the real-time PCR testing allowed for the
detection of Chlamydia trachomatis, Neisseria gonorrhoeae,a n dT. vaginalis from a single specimen.
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Introduction
Trichomonas vaginalis is one of the most common
sexually transmitted diseases, with an estimated 5
million cases per year in the United States [1] and as
many as 200 million cases annually worldwide. In
women, common symptoms of T. vaginalis infection
include vaginal discharge and vulval irritation.
Complications of T. vaginalis infection can occur in
untreated women and include endometritis, inferti-
lity and cervical erosion [2,3]. In pregnant women,
T. vaginalis infections can lead to severe complica-
tions including premature rupture of membranes [4],
preterm deliveries and low-birth-weight infants [4].
In men, T. vaginalis infection is a cause of non-
gonococcal urethritis, [5] and if untreated may lead
to complications including chronic prostatitis, ure-
thral strictures, epididymitis and/or infertility [2,3].
T. vaginalis infection is also associated with an
increased risk of acquiring human immunodeﬁciency
virus type 1 (HIV-1) infection [6–9], which is related
to local inﬂammation within the genital tract that
occurs with T. vaginalis infections. It has been
estimated that between 10% and 50% of T. vaginalis
infections are asymptomatic [10], supporting the
need for more intensive screening for T. vaginalis
infections in sexually active men and women as well
as pregnant women.
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infection include microscopic examination of wet-
mount preparations, culture and, more recently,
polymerase chain reaction (PCR). Wet mount
examination of genital discharge material is rapid
and inexpensive, but the sensitivity is only 40% to
70% [11]. This poor sensitivity may be due in part to
the rapid loss of the characteristic protozoan motility
once the organism has been removed from an
environment at 378C. Currently, broth culture is
considered to be the gold standard for detecting T.
vaginalis [12]. Successful growth in culture can be
achieved with as few as 300 to 500 TV organisms per
milliliter of vaginal ﬂuid, but requires 2 to 7 days of
incubation and daily microscopic examination for
optimal performance. However, the sensitivity of
culture is also low, ranging from 50% to 80%. In
addition, culture requires a specialized medium such
as Diamond’s broth or Tricosal medium. These
limitations of wet-mount examination and culture
has led to interest in using molecular assays for the
detection of T. vaginalis DNA from clinical speci-
mens. PCR assays have been developed that are
speciﬁc and show an improved sensitivity compared
with both culture and wet-mount examination [13–
17].
The majority of sexually transmitted diseases
occur in adolescents and, although screening for
sexually transmitted disease has been shown to be
cost effective, compliance with testing, particularly
among teenagers, remains an important challenge
[18]. Self-collected vaginal swabs offer a method of
testing adolescent women that could improve com-
pliance with testing, and a recent study has shown
that this approach can be easily implemented in a
high-school setting, with high acceptability [13].
Thus, self-collection of vaginal swabs improves the
diagnosis and treatment of sexually transmitted
diseases in adolescents. In this study, we compared
the sensitivity of a real-time PCR assay with culture
for the diagnosis of T. vaginalis infections using self-
collected vaginal swabs. Specimens were collected
using the BDProbeTec ET Culturette Direct Dry
Swab system, allowing for simultaneous testing for
Chlamydia trachomatis, Neisseria gonorrhoeae and T.
vaginalis from a single specimen.
Subjects and methods
Patients and samples
Samples were collected from African-American
adolescent and young adult females enrolled in one
of two HIV-1 prevention programs. In the ﬁrst study,
females aged 15 to 21 years were recruited from a
county clinic for sexually transmitted diseases. The
second study included women between the ages of
18 to 29 years, who were enrolled at Kaiser
Permanente in Atlanta, Georgia, USA. As part of
the study, the participants provided self-collected
vaginal swab samples to be tested for C. trachomatis,
N. gonorrhoeae and T. vaginalis. Both studies were
approved by the Emory University Institutional
Review Board (#327–99, #534–2002). Participants
collected two vaginal swabs, one for T. vaginalis
culture and the other for C. trachomatis, N. gonor-
rhoeae and T. vaginalis nucleic acid testing. The
results of the C. trachomatis and N. gonorrhoeae
testing were not included in this study.
For T. vaginalis culture, the specimens were
collected using Dacron tip swabs. They were
inoculated into the InPouch TV System (BioMed
Diagnostics, San Jose, CA, USA) onsite, and were
transported to the clinical laboratory where they were
immediately incubated at 378C. For T. vaginalis
PCR testing, self-collected vaginal swabs were
obtained using the BDProbeTec ET Culturette
Direct Dry Swab system (Becton Dickinson, Sparks,
MD, USA) and transported to the laboratory on
icepacks. They were refrigerated until processed,
which was carried out within 6 days of collection.
Trichomonas vaginalis culture
T. vaginalis cultures were performed in the Clinical
Microbiology Laboratory at Emory University Hos-
pital following standard procedures. The specimens
were incubated at 378C and examined at 72 hours
for the presence of T. vaginalis trophozoites.
T. vaginalis real-time PCR assay
The vaginal swabs collected in the BDProbeTec ET
Culturette Direct Dry Swab system were processed
as outlined by the manufacturer for cervical swabs.
Brieﬂy, the swabs were placed in a vial of BDPro-
beTec ET diluent (2 ml); the swab was swirled in the
diluent for 5 to 10 seconds and then removed. The
tubes were then incubated at 112
oC to 1168Ci na
dry bath for 30 minutes. An aliquot of the sample
was used for T. vaginalis PCR testing. The target for
the real-time PCR assay was a 67-base pair region of
a repeated sequence of the T. vaginalis genome [19]
(Gene Bank Accession Number L23861). The
primers and probes were designed using Primer
Express (Applied Biosystems, Foster City, CA,
USA). The PCR reaction contained 25 mlo f2 X
TaqMan
1 Universal Master Mix (Applied Biosys-
tems, manufactured by Roche, Branchburg, NJ,
USA), 5 ml each (ﬁnal concentration 900 nM) of
primer TV forward (5’ CAT TGA CCA CAC GGA
CAA AAA G 3’) and primer TV reverse (5’ CGA
AGT GCT CGA ATG CGA 3’), 5 ml (ﬁnal
concentration 225 nM) of probe (5’FAM - TCA
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3’) and 5ml of sample DNA. The samples were
ampliﬁed in an ABI Prism 7000 Sequence Detector
(Applied Biosystems, Foster City, CA, USA) using
the following thermal cycling conditions: 508C for 2
minutes, 958C for 10 minutes, followed by 40 cycles
at 958C for 15 seconds, and at 608C for 1 minute.
Each run included a positive and negative control. A
positive T. vaginalis result was deﬁned as a cycle
threshold (Ct) less than 40; samples with a Ct of
438 and 540 were repeated to conﬁrm the result.
All samples with a Ct 438 and 540 on the initial
run were conﬁrmed on repeat testing.
Culturing T. vaginalis in the InPouch TV System
and then counting the organisms using a hemocyt-
ometer determined the limit of detection of the assay.
The T. vaginalis organism was obtained from
BioMed Diagnostics (San Jose, CA, USA). The
limit of detection was 50.2 organisms per reaction.
The speciﬁcity of the assay was assessed by testing
a variety of organisms commonly isolated from
the female genital tract, including Escherichia coli,
Candida albicans, Enterococcus faecalis, Gardnerella
vaginalis, Staphylococcus aureus and Lactobacillus
acidophilus, and genital pathogens including cyto-
megalovirus, herpes simplex virus, Chlamydia tracho-
matis and Neisseria gonorrhoeae. In addition, cultures
of normal vaginal ﬂora grown on sheep blood agar
obtained from the Clinical Microbiology Laboratory
were also tested in the assay. All of these specimens
tested negative for T. vaginalis DNA in the real-time
PCR assay.
Conﬁrmatory T. vaginalis PCR assay
Discrepant specimens that were culture negative and
positive by the real-time PCR assay were also tested
in a conﬁrmatory PCR assay that targets a different
region of the T. vaginalis genome. For this testing an
aliquot of the specimen, which had been stored at
7708C, was sent to a second laboratory for
conﬁrmatory PCR testing. The conﬁrmatory PCR
assay ampliﬁed a 312-base pair region of the 18S
ribosomal DNA gene [20]. One ml of the extracted
sample was added to a 50 ml volume of master mix
comprising 1X Qiagen Hotstar buffer (Qiagen Inc,
Valencia, CA, USA), 0.4 mM of each primer (TV1:
5’ TAA TGG CAG AAT CTT TGG AG 3’, TV2:
GAA CTT TAA CCG AAG GAC TTC 3’),
200 mM dNTPs (with UTP), 1.25 U Qiagen Hotstar
Taq and 0.5 U AmpErase (Applied Biosystems,
Foster City, CA, USA). The reaction was ampliﬁed
in a Gene Amp 9600 (Applied Biosystems, Foster
City, CA, USA) using the following parameters: 10
minutes at room temperature, 15 minutes at 958C,
then 40 cycles of 30 seconds at 958C, 1 minute at
578C and 30 seconds at 728C. The product was
visualized on a 3% agarose gel (Nusieve GTG).
Positive and negative controls were included in each
run. A visible band in the gel at the appropriate
molecular weight was considered a positive result.
Statistical analysis
Differences in Ct values between the culture-
positive/real-time PCR-positive specimens and
the culture-negative/real-time PCR-positive/conﬁr-
matory PCR positive specimens were analyzed
using Student’s t-test.
Results
The real-time PCR assay had a limit of detection of
50.2 organism per reaction, which was equivalent
to approximately 40 copies/ml of specimen. A
representative standard curve is shown in Figure 1.
The assay was speciﬁc for T. vaginalis; there was no
cross-reactivity with other genital pathogens or
organisms found in normal vaginal ﬂora (see
Methods for a list of the organisms tested).
A total of 524 pairs of specimens were tested by
culture and real-time PCR: 36 specimens were
positive for T. vaginalis by culture and 54 were
positive for T. vaginalis DNA by PCR (Table I).
Using culture as the gold standard, the real-time
PCR assay had a sensitivity of 100% and a speciﬁcity
of 96.3%. The 18 specimens that were positive by
real-time PCR and culture negative, as well as 36
specimens that were negative by real-time PCR and
culture, were tested in a conﬁrmatory PCR assay,
which targeted a different region of the T. vaginalis
genome. All 36 of the specimens negative by culture
and the real-time PCR assay were also negative by
the conﬁrmatory PCR assay; 16 of the 18 specimens
Figure 1. A representative standard curve for the real-time
Trichomonas vaginalis PCR assay. The log10 concentration of T.
vaginalis DNA (organisms/ml of specimen) is plotted against the
Ct value.
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time PCR assay, were positive in the conﬁrmatory
PCR assay (Table II). These 16 specimens were
considered true positive results, whereas the 2
specimens that were not positive in the conﬁrmatory
PCR assay were considered false positive results. The
Ct values on the real-time PCR assay for the false-
positive specimens were 35.1 and 39.4. Using a
modiﬁed gold standard of positive by culture or
positive in both PCR assays, the sensitivity of the
real-time PCR assay was 100% and the speciﬁcity
was 99.6%, whereas culture had a sensitivity of
69.2% and a speciﬁcity of 100%. Using the modiﬁed
gold standard, the prevalence of T. vaginalis infection
in our population was 10% (52 of 524) and the
positive predictive value of the real-time PCR assay
was 96.3% with a negative predictive value of 100%.
To assess the organism burden in the various
samples, the Ct values were compared between the
36 culture-positive/real-time PCR-positive speci-
mens, the 16 culture-negative/real-time PCR-
positive/conﬁrmatory PCR-positive specimens, and
the 2 culture-negative/real-time PCR-positive/con-
ﬁrmatory PCR-negative specimens (Figure 2). The
range in Ct values for the 36 specimens that were
culture positive/real-time PCR positive was 18.3 to
39.1, with a median value of 25.6 and a mean of
26.2. For the 16 specimens that were culture
negative/real-time and conﬁrmatory PCR positive,
the range in Ct values was 16.1 to 39.8, with a
median of 35.1 and a mean of 33.7. The difference
(D7.5) was statistically signiﬁcant (p50.0001), and
on average the concentration of T. vaginalis DNA in
the culture-positive/real-time PCR-positive speci-
mens was 42 log10 higher than that observed in
the culture-negative/real-time and conﬁrmatory
PCR-positive specimens.
Discussion
We developed a real-time PCR assay for the
detection of T. vaginalis that was both sensitive and
speciﬁc. This study conﬁrms the results of others
[14–17,21] in showing that PCR testing was more
sensitive than culture for the detection of T.
vaginalis; in this study, the real-time PCR assay
detected about 40% more positive samples than
culture. This increase in sensitivity was obtained with
very little loss of speciﬁcity, i.e., 99.6% for the PCR
assay compared with 100% for culture. Although the
real-time PCR assay was not designed to quantify the
amount of T. vaginalis DNA in the specimen, the Ct-
value was inversely related to the concentration of
DNA in the specimen: samples with a low organism
burden have a higher Ct value. The comparison of Ct
values between the culture-positive, real-time PCR-
positive specimens and the culture-negative, real-
time and conﬁrmatory PCR-positive specimens,
showed that the real-time PCR assay was positive
in a greater number of specimens with a low
organism burden than was culture. This improve-
ment in detecting infection in samples with a low
organism burden should be useful when testing
asymptomatic individuals, who might be expected to
have a lower burden of organism than those with
symptoms. The 2 samples that were not positive in
the conﬁrmatory PCR assay had a low amount of T.
vaginalis DNA as evidenced by the high Ct values
(39.4 and 35.1). It is possible that these were false-
positive results due to contamination, although the
Table I. Comparison of culture and real-time PCR for the
detection of T. vaginalis.
Culture
Real-time PCR Positive Negative
Positive 36 18
Negative 0 470
PCR, polymerase chain reaction; real-time PCR sensitivity=
100%, speciﬁcity=96.3%.
Table II. Comparison of culture and real-time PCR for the
detection of T. vaginalis.
Culture/conﬁrmatory PCR
Real-time PCR Positive Negative
Positive 52 2
Negative 0 470
PCR, polymerase chain reaction; real-time PCR sensitivity=
100%, speciﬁcity=99.6%.
Figure 2. Ct values for culture-positive, real-time PCR-positive
(Cx+/PCR+), culture-negative, real-time and conﬁrmatory
PCR-positive (Cx-/PCR+conﬁrmed) and culture-negative, real-
time PCR-positive, conﬁrmatory PCR-negative (Cx-/PCR+un-
conﬁrmed) samples. The line represents the mean Ct value.
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This discrepancy may have also been due to
differences in sensitivity between the two PCR assays
because of differences in the size of the amplicons, or
the number of copies of the target present per
genome. Alternatively, there may have been degra-
dation of DNA during storage, before testing in the
conﬁrmatory PCR assay.
The BDProbeTec ET Chlamydia trachomatis and
Neisseria gonorrhoeae tests are FDA cleared for
detection of these pathogens in urethral, endocervi-
cal and urine specimens and are widely used in
clinical laboratories. In this study we successfully
used the BDProbeTec ET Culturette Direct Dry
Swab system for T. vaginalis PCR testing. This is
important because it allows for the collection of one
specimen that is adequate for C. trachomatis, N.
gonorrhoeae and T. vaginalis testing, so that im-
plementation T. vaginalis screening becomes con-
venient for both the clinician and the laboratory.
We have also successfully used the NAT
TM-Nucleic
Acid Transport Female Collection Kit (Medical
Packaging, Camarillo, CA, USA) System collection
devices for T. vaginalis PCR testing (data not
shown). Other collection devices will need to be
assessed to assure that they are compatible with
PCR assays and do not contain inhibitors of
ampliﬁcation.
One of the limitations of the real-time PCR assay is
that it does not include an internal control to
monitor for inhibition. However, an aliquot of the
dry swab specimen was also tested for C. trachomatis
and N. gonorrhoeae using the BDProbeTec ET assay,
and inhibition of ampliﬁcation was not observed in
any these specimens (data not shown). However,
since rates of inhibition vary for different ampliﬁca-
tion methods, we cannot rule out the possibility of
false-negative results with the real-time PCR assay.
Another limitation of this study is that not all of the
samples were tested in both of the PCR assays.
However, the 36 specimens that were negative by
culture and real-time PCR were also negative in the
conﬁrmatory PCR assay. So it is unlikely that a
signiﬁcant number of additional positive specimens
would have been detected if all 470 culture-negative,
real-time PCR negative specimens were tested in the
conﬁrmatory PCR assay.
Thus, a real-time PCR assay has been designed
using self-collected vaginal swabs, that is more
sensitive than culture for the detection of T.
vaginalis, has a high speciﬁcity (499%), and offers
the convenience of using the BDProbeTec ET
Culturette Direct Dry Swab system for specimen
collection. This real-time PCR assay as designed
provides a simpliﬁed approach to improving the
detection of T. vaginalis infection, improving com-
pliance in high-risk groups. Such an improvement,
according to what has been observed for C.
trachomatis infection, would be predicted to reduce
the incidence of T. vaginalis infection, possibly to
reduce HIV-1 transmission and even to reduce poor
pregnancy outcomes.
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